Details of the Drug

General Information of Drug (ID: DMY4LTE)

Drug Name

VIMO-001

Synonyms

alpha-tocopheryloxyacetic acid; alpha-TEA; JW7FJR3ZLY; UNII-JW7FJR3ZLY; aTEA; 2-[[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]acetic acid; 261929-52-6; SCHEMBL2142535; CHEMBL2152999; DTXSID8041167; ZINC3974003; Q27896667; (2,5,7,8-Tetramethyl-(2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy)acetic acid; 2,5,7,8-Tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxyacetic acid; ({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-yl}oxy)acetic acid; Acetic acid, (((2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)-

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C31H52O4
Canonical SMILES: CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OCC(=O)O)C
InChI: 1S/C31H52O4/c1-21(2)12-9-13-22(3)14-10-15-23(4)16-11-18-31(8)19-17-27-26(7)29(34-20-28(32)33)24(5)25(6)30(27)35-31/h21-23H,9-20H2,1-8H3,(H,32,33)/t22-,23-,31-/m1/s1
InChIKey: LCFWOFKPFDWYLR-CEFNRUSXSA-N

Cross-matching ID

PubChem CID: 9913401
CAS Number: 261929-52-6
TTD ID: D5GI0O

References

1	Clinical pipeline report, company report or official report of Veana Therapeutics.